Last reviewed · How we verify
Treatment of TongBi Capsule — Competitive Intelligence Brief
phase 3
Traditional Chinese medicine
Respiratory
Small molecule
Live · refreshed every 30 min
Target snapshot
Treatment of TongBi Capsule (Treatment of TongBi Capsule) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. TongBi Capsule is used to treat symptoms of chronic bronchitis and asthma by improving lung function.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Treatment of TongBi Capsule TARGET | Treatment of TongBi Capsule | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | phase 3 | Traditional Chinese medicine | ||
| Yangxinshi tablet simulants | Yangxinshi tablet simulants | Dongzhimen Hospital, Beijing | marketed | Traditional Chinese medicine herbal formulation | ||
| Placebo of Gastrodia and Uncaria granule | Placebo of Gastrodia and Uncaria granule | Shanghai Institute of Hypertension | marketed | Herbal medicine / Traditional Chinese medicine | ||
| Abelmoschus manihot (AM) | Abelmoschus manihot (AM) | Chinese PLA General Hospital | marketed | Herbal extract / Traditional Chinese Medicine | ||
| Louxiangdan Tongxin granules | Louxiangdan Tongxin granules | Liaoning University of Traditional Chinese Medicine | marketed | Traditional Chinese medicine herbal formulation | ||
| Erigeron breviscapus injection | Erigeron breviscapus injection | Guangzhou University of Traditional Chinese Medicine | marketed | Traditional Chinese medicine extract; antiplatelet/microcirculation enhancer | ||
| Twice Normal-dose Wenxin Granules | Twice Normal-dose Wenxin Granules | China Academy of Chinese Medical Sciences | marketed | Traditional Chinese medicine herbal formulation |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Traditional Chinese medicine class)
- Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
- Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
- Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
- Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
- China Academy of Chinese Medical Sciences · 1 drug in this class
- The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
- Dongzhimen Hospital, Beijing · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Treatment of TongBi Capsule CI watch — RSS
- Treatment of TongBi Capsule CI watch — Atom
- Treatment of TongBi Capsule CI watch — JSON
- Treatment of TongBi Capsule alone — RSS
- Whole Traditional Chinese medicine class — RSS
Cite this brief
Drug Landscape (2026). Treatment of TongBi Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-of-tongbi-capsule. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab